Q3 2021 Regulus Therapeutics Inc Earnings Call Transcript
Good afternoon, ladies and gentlemen, and welcome to the Regulus Therapeutics Inc. Quarter 3, 2021 Conference Call. (Operator Instructions) As a reminder, this conference call is being recorded. I'd now like to turn the conference over to your host, Ms. Cris Calsada, Chief Financial Officer. You may begin.
Thanks, operator. Good afternoon, and thank you for joining us to discuss Regulus Therapeutics Third Quarter 2021 financial results and corporate highlights. With me on today's call is Jay Hagan, President and Chief Executive Officer; and Denis Drygin, Chief Scientific Officer. Jay will provide opening remarks and share progress on our ADPKD program and I will review the financial results before we open the lines for questions.
Before we begin, I'd like to remind you that this call will contain forward-looking statements concerning Regulus' Therapeutic's future expectations plans, prospects, corporate strategy and performance, which constitute forward-looking statements for the purposes of the safe harbor provision under the Private Securities
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |